Average cost per year*
Average cost per beneficiary*
Asenapine maleate is a prescription medication used to treat certain mental health conditions, including schizophrenia and bipolar disorder. It helps manage symptoms associated with these disorders. However, it is essential to understand that Asenapine maleate does not provide a cure. To experience the best results and minimize potential side effects, take Asenapine maleate as directed by your healthcare provider. Regular communication and follow-up with your healthcare professional are vital during treatment. This summary offers a general overview and may not encompass all available information about the product. It does not guarantee the product's safety, effectiveness, or appropriateness for your unique needs. Consult your healthcare professional for comprehensive information and individualized guidance.
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Yes, Asenapine Maleate is covered by Medicare.
In 2021, the average cost per dose of Asenapine Maleate was $8.36.
The average dose of Asenapine Maleate received per year is 581,567 units
10,523 Medicare beneficiaries received Asenapine Maleate in 2021, which was a 33.39% from 2020
There were 55,580 claims made by Medicare beneficiaries, which is a 165.91% from 2020
The average spending amount per claim in 2021 was $432.99
The average Medicare spending per beneficiary amount for Asenapine Maleate was $2,286.94
The most expensive manufacturer of Asenapine Maleate is Alembic Pharmac
Sigmapharm Labo is the least expensive manufacturer with an Average Spending Per Dosage Unit of $3.37
Greenstone LLC. received $12,139,721.99
The total amount spent on Asenapine Maleate by Medicare is $24,065,457.85
Short Term Medical Insurance
Limited Fixed Indemnity Plans